key: cord-0427173-mhn7ugev
authors: Kennedy, J. L.; Forrest, J. C.; Young, S. G.; Amick, B.; Williams, M.; James, L.; Snowden, J.; Cardenas, V.; Boothe, D.; Kirkpatrick, C.; Modi, Z.; Caid, K.; Owens, S.; Kouassi, M.; Mann, R.; Putt, C.; Irish-Clardy, K.; Macechko, M.; Brimberry, R. K.; Nembhard, W. N.; Du, R.; Jin, J.; Zohoori, N.; Kothari, A.; Hagrass, H.; Olgaard, E.; Boehme, K. W.
title: Temporal Variations in Seroprevalence of SARS-CoV-2 Infections by Race and Ethnicity in Arkansas.
date: 2021-07-19
journal: nan
DOI: 10.1101/2021.07.15.21260213
sha: f3586022f8d3d9ad85138178fa6eb5fafee20bf1
doc_id: 427173
cord_uid: mhn7ugev

Objective: Our objective is to estimate CoV-2 infection rates in a rural state using seroprevalence of antibodies to CoV-2 as an indicator of infection. Study Design and Setting: This is a single-site study within an academic center and regional programs within the state of Arkansas. We obtained residual serum samples from a convenience sample of adults who were outpatients and came to the hospital or regional clinic for non-COVID-related reasons. We collected remnant in three time periods (August 15 to September 5, September 12 to October 24, and November 7 to December 19). Results: In 2020, the overall age, gender, and race standardized prevalence of CoV-2 antibodies was 2.6% (August to September), 4.1% (September to October), and 7.4% (November to December). There was no difference in seroprevalence between urban compared to rural areas. Positive tests were not uniformly distributed across racial and ethnic minorities. Higher seroprevalence rates were found in Hispanics and Blacks or African Americans compared to whites across all time periods. Conclusions: In a state with a large rural population, 2.6-7.4% of people experienced CoV-2 infection by December 2020. Blacks and Hispanics had disproportionately higher rates of CoV-2 infections than whites.

Since emerging in 2019, Severe Acute Respiratory Syndrome Coronavirus-2 (CoV-2) has spread around the world causing high morbidity and mortality [1] [2] [3] [4] . CoV-2 infections in the United States (US) were initially concentrated in densely populated areas, but later spread to rural areas [5] [6] [7] . Further, significant racial and ethnic disparities in the rates of CoV-2 infection are noted with a higher prevalence in Black and Hispanic persons [4, 8] .

With limited testing and inconsistent symptom severity, including a spectrum of asymptomatic to fatal infections, the true prevalence of CoV-2 infections has been difficult to determine. Some reports estimate that 40 to 45% of cases of CoV-2 may be asymptomatic [9, 10] . Asymptomatic cases affect our ability to contain CoV-2 within the population because the virus can be spread surreptitiously to others [11, 12] . Many in the scientific community now recognize the best way to evaluate the effect of asymptomatic cases on CoV-2 spread and to determine when herd immunity may be reached is population-based seroprevalence surveys [13, 14] . These surveys provide valuable information to public health officials as they consider decisions related to the pandemic.

Arkansas, a small state in the southern US with an ethnically-and racially-diverse population of approximately 3.2 million, provides an opportunity to determine CoV-2 seroprevalence in urban vs. rural populations and evaluate racial and ethnic disparities in a temporal fashion. According to US census reports, the four largest ethnic groups in the state are White (Non-Hispanic) 72.1%, Black (Non-Hispanic) 15 .1%, White (Hispanic) 4.38%, and Other (Hispanic) 2.66% [9] . This report describes the variations of CoV-2 infection over time (August to December 2020) by age, gender, race/ethnicity, and rurality based on serologic testing in the state.

Human specimens. Remnants from serum samples collected for routine, non-COVID-19related outpatient clinical laboratory tests that would otherwise be discarded were obtained from . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 19, 2021. ;  https://doi.org/10.1101/2021.07.15.21260213 doi: medRxiv preprint the University of Arkansas for Medical Sciences (UAMS) main campus in central Arkansas and three regional campuses located in northwest (Springdale and Fort Smith) and southeast Arkansas (Pine Bluff). The study was reviewed and approved by the UAMS Institutional Review Board and waiver of consent and HIPAA applied.

Inclusion criteria for serum collection were age 18 years or older, Arkansas resident, and outpatient source. Samples were excluded with the following diagnosis codes: immunodeficiency (primary immune deficiency (D80-D89), transplant recipient (all codes beginning with Z94), and cancer (C00-D49)). In addition, samples from patients with chemotherapy (prior two months), steroids (prior 30 days), and/or intravenous immunoglobulin (prior 6 months) were excluded. Criteria for selection of samples were provided to an honest broker to create lists of subjects twice weekly from the UAMS electronic health record, known as the Arkansas Central Data Repository (AR-CDR). Samples were selected from Fort Smith, Pine Bluff, and Northwest Arkansas by staff at each site after they were considered remnant. All clinical and demographic variables were stored in a protected REDCap database [10, 11] and included patient age, gender, race, ethnicity, ZIP Code, and county of residence. Patient ZIP Codes were cross referenced with the Federal Office of Rural Health Policy's data files identifying non-metropolitan counties and rural census tracts that comprise the rural area in our study [12] .

Laboratory Methods. A two-step process was used to evaluate the sera for CoV-2 antibodies, as suggested by Centers for Disease Control (CDC) guidelines [13] . All sera were tested for CoV-2 Receptor Binding Domain (RBD) IgG antibodies using the Beckman Coulter (BC) Access . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) Specimens scored as reactive by BC and 5% of the negative-scoring samples were confirmed using a laboratory-developed enzyme-linked immunosorbent assay (ELISA). A final result of "positive" required that both assays indicated reactivity.

The laboratory-derived assay in this study was designed considering prior ELISAs for CoV-2 antibodies [14] . Plates were coated with CoV-2 RBD, Spike, Nucleoprotein, and bovine serum albumin (BSA) (negative control) diluted to 2 µg/mL. Plates were then washed three times with PBS + 0.1% Tween-20 (PBS-T) and blocked for up to 4h with 200 μL of PBS-T + 3% milk. Serum samples were diluted 1:50 in PBS-T + 1% milk. CoV2-positive serum and pre-COVID-19 sera were utilized as a positive and negative control, respectively, and all samples were run in duplicate. Blocking reagent was removed and 50 µL of diluted serum or controls were added in the plates were incubated at RT for 2h. The plates were washed three times with PBS-T and incubated with 50 µL of secondary antibody solution anti-human IgG + IgM (Jackson ImmunoResearch) diluted 1:5000 in PBS-T + 1% milk) for 1h at RT. Then, the plates were washed three times with PBS-T and 75 µL of SureBlue TMB . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) Due to the outcome rate <10%, a bias-reducing penalized likelihood optimization was applied for all the logistic regression fittings [15] . Goodness-of-fit was examined by the Deviance test results which did not suggest model fitting concerns. Statistical significance was set at 0.05.

All analyses were conducted using SAS, version 9.4. and graphics were done using R, version 4.0.2, and ArcGIS Pro, version 2.7.3.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 19, 2021. ; https://doi.org/10.1101/2021.07.15.21260213 doi: medRxiv preprint

Cohort characteristics. We collected 1,301 adult remnant serum samples from four sites between time period 1, 2098 for time period 2, and 2405 for time period 3 for a total sample collection of 5804. Table 1 provides summary data for demographic characteristics for each time period. While a majority of the samples came from northwest, southeast, and central Arkansas, we did have samples representing 74/75 counties in Arkansas during our collection time points ( Figure 1 ).

The observed raw seroprevalence rates were 3.8%, 4.9%, and 8.1% for the three time periods, respectively ( Table 2 ). Both the unadjusted and adjusted association study results show that race/ethnicity is significantly associated with the positive CoV-2 antibodies (Tables 2 and 3 ). The estimates obtained from the remnant samples were standardized by the distribution of age, gender and race/ethnicity of the Arkansas general population. The standardized rate per 100 persons was 2.6% (95%CI 1.7-3.5), for time period 1.

For time period 2, we found a standardized seroprevalence of 4.1% (95%CI 3.1-5.1).

Seroprevalence increased slightly in time period 3 where we saw an age-, gender, and race/ethnicity-standardized rate of 7.4% (95%CI 6.0-8.7) (Figure 2 ). of Whites had antibodies to CoV-2 ( Figure 3 ). For each racial/ethnic group we evaluated, we observed a consistent increase in seroprevalence over the course of study; however, the . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 19, 2021. ; https://doi.org/10.1101/2021.07.15.21260213 doi: medRxiv preprint difference between time periods was not significant for the Hispanic cohort due to large data variation related to relative sample sizes for this group (Table 4) . During all three time periods, we noticed that Black and Hispanic populations had a higher chance of contracting the virus relative to White participants when adjusted for other variables (Table 3, Figure 4) . A logistic regression fitting model showed that the increased slope of seroprevalence by time period for Hispanics was significantly lower compared to the slope for White (OR: 0.49, 95% CI: 0.3-0.78) ( Table 5 ). In other words, although the positivity to CoV-2 was higher in Hispanic individuals compared to White individuals, this difference became smaller over the time course of the study.

We obtained the same direction of the estimate for Black individuals, but there was not a statistical difference for Blacks compared to Whites (OR: 0.75, 95% CI: 0.5-1.12).

During the time course of this study, we noticed differences between the seroprevalence in different age groups in the univariable analysis ( (Table 2 ). However, with the multivariable analysis, these differences disappeared (Table 3 ). There were also no specific differences noted in any time periods between genders ( Figure 4 ).

There was no statistically significant difference between seroprevalence in samples from rural and urban ZIP Code Tabulation Areas at any time point of the study. Early in the pandemic, urban areas had a slightly higher seroprevalence over rural (Time period 1: 3.9% urban, 2.9% rural; Time period 2: 5.0% urban and 4.2% rural); in time period 3, we observed a higher seroprevalence in rural over urban (7.7% urban vs. 9.7% rural). This observation is consistent with national data that urban areas may have had higher prevalence of infections in the beginning of the pandemic, but rural . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 19, 2021. ; https://doi.org/10.1101/2021.07.15.21260213 doi: medRxiv preprint areas increased prevalence with time, although the effect in our study was not statistically significant (Tables 2 and 3) .

We also examined changes in seroprevalence by week. There was a gradual increase throughout the study that corresponded with increasing proportions of people infected with CoV-2 as diagnosed by molecular means. As expected, the peak of seroprevalence was noted in time period 3 towards the end of the study period with values ranging from 5.3% to 13.7% ( Figure 5 ). Rates for racial/ethnic groups were monitored by time period and also increased accordingly with time. Seroprevalence of CoV-2 antibodies amongst Black and Hispanic individuals was consistently higher throughout the course of the study as compared to Whites. The trend test ( was low compared to high population centers or high-risk groups [16] [17] [18] [19] , indicating that most Arkansans were immune naïve to the virus during the study time period, seroprevalence did increase over time in all subpopulations.

Our study using medical remnant samples found that the standardized CoV-2 seroprevalence rate increased from 2.6%-7.4% in Arkansas from August to December 2020.

During the last week of the study, the raw seroprevalence rate approached 14%. For comparison, the Arkansas Department of Health reported a total of 213,267 confirmed or suspected CoV-2 infections as of December 25, 2020 -roughly equivalent to 7% of the Arkansas population. Based on these numbers, it is possible that our sampling detected many asymptomatic and untested people who were previously infected with CoV-2 in our state. Many people with CoV-2 infection, . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 19, 2021. ; https://doi.org/10.1101/2021.07.15.21260213 doi: medRxiv preprint including those with mild or asymptomatic infections that are likely driving the disconnect observed between the seroprevalence and acute CoV-2 infections, may go on to develop post-COVID conditions such as "long COVID" and multiorgan dysfunction. Therefore, it is imperative that seroprevalence data be coupled with acute testing results from PCR and other modalities to inform healthcare resource allocation and manage the true burden of acute and post-COVID morbidity as the pandemic progresses.

We found higher seroprevalence in Hispanics and Blacks compared to whites throughout the study. However, a temporal trend of the data showed that the increase in the white population was more than that in the Hispanics or Blacks during the same time period. Anecdotally, Hispanics and Blacks in our state were noted to have higher rates of PCR positive tests early in the course of the time periods. Ultimately, the rates of Hispanics and Blacks who had positive PCR tests leveled over the course of our study, which explains the lower odds ratios and change in effect size associated with these groups.

Our findings that younger age, race, and ethnicity correlate with a higher rate of previous CoV-2 infection in Arkansas agree with the American Red Cross data for southern states and the broader US population as a whole [21] . Any attempt to explain the racial/ethnic disparities observed in this study would be speculative, but the data fit with a broader theme highlighting the need to understand biologic, social, and demographic factors that impact health in underrepresented minority populations.

In addressing potential differences between rural and urban areas of the state, our findings suggest that CoV-2 has spread uniformly across urban and rural areas of the state.

This finding was somewhat surprising given that urban areas were more greatly impacted in the northeast and northwest US, and in southern cities such as Houston and New Orleans.

However, it is worth noting that Arkansas was home to a rural super-spreader event in March of 2020 [23] . These data suggest that those in rural areas of the state are just as likely to have been infected with CoV-2 as those in urban population centers.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 19, 2021 [20] . It is possible that our sampling method could favor subjects who were more ill (e.g., individuals who were hospitalized) or more willing to leave their homes (e.g., individuals when were evaluated in clinics), etc. Nonetheless, the seroprevalence observed is consistent with both reported infections and data from American Red Cross blood donations in southern US states [21] and the Centers for Disease Control Multi-State Assessment of SARS-CoV-2 Seroprevalence (MASS-C) [22] , which increases confidence in our data. The American Red Cross blood study found only 2.9% seroprevalence from August to September in southern states, while the MASS-C data revealed 9.2% seroprevalence in December in Arkansas. It should be noted that these earlier studies had no [17] or low (n=1071 Arkansas samples) [22] representation from Arkansas. Taken together, the data support the conclusion that the while seroprevalence rates demonstrate that more Arkansans have been infected with CoV-2 than previously recognized, the majority of the population in a representative rural southern state was not infected by CoV-2 from March to December of 2020. This, in combination with slow vaccine uptake despite rapid distribution of vaccinations across the State, has left many people vulnerable to CoV-2 infection with variants of concern. In fact, this spring, Arkansas is experiencing an uptick in cases, ranking second in highest number of cases per 100,000 people.

Seroprevalence studies play a critical in defining the scope of the CoV-2 pandemic. In a state with a large rural populace, serologic analysis of remnant samples suggest that CoV-2 infection has been more widespread than acute testing reflects. Additionally, Hispanic and Black Arkansans had disproportionately higher rates of CoV-2 infections. This study highlights the need to understand factors that impact health in underrepresented minority populations and the key role seroprevalence will play in understanding the CoV-2 pandemic.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 19, 2021. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 19, 2021 Error bars indicate the 95% CI. Note the high Odds Ratios associated with Hispanics and Black or African Americans compared to Whites throughout the study. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted July 19, 2021. ; https://doi.org/10.1101/2021.07.15.21260213 doi: medRxiv preprint . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted July 19, 2021. ; https://doi.org/10.1101/2021.07.15.21260213 doi: medRxiv preprint . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted July 19, 2021. ; https://doi.org/10.1101/2021.07.15.21260213 doi: medRxiv preprint CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted July 19, 2021. ; https://doi.org/10.1101/2021.07.15.21260213 doi: medRxiv preprint

COVID 19 -Clinical Picture in the Elderly Population: A Qualitative Systematic Review

National age and coresidence patterns shape COVID-19 vulnerability

COVID-19 and Older Adults: What We Know

COVID-19: risk accumulation among biologically and socially vulnerable older populations

Estimated SARS-CoV-2 Seroprevalence in the US as of

SARS-CoV-2 Seroprevalence among a Southern U.S. Population Indicates Limited Asymptomatic Spread under Physical Distancing Measures

Seroprevalence of Antibodies to SARS-CoV-2 in 10 Sites in the United States

Racial and Ethnic Disparities in COVID-19-Related Infections, Hospitalizations, and Deaths : A Systematic Review

Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support

The REDCap consortium: Building an international community of software platform partners

Interim Guidelines for CoVID-19 Antibody Testing

SARS-CoV-2 Seroconversion in Humans: A Detailed Protocol for a Serological Assay, Antigen Production, and Test Setup

Bias Reduction of maxmum likelihood estimates

SARS-CoV-2 seropositivity and subsequent infection risk in healthy young adults: a prospective cohort study

SARS-CoV-2 Infection Risk Among Active Duty Military Members Deployed to a Field Hospital

SARS-CoV-2-Specific Neutralizing Antibody Responses in Norwegian Health Care Workers After the First Wave of COVID-19 Pandemic: A Prospective Cohort Study

Seroconversion in household members of COVID-19 outpatients

Estimation Without Representation: Early Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence Studies and the Path Forward

Change in Donor Characteristics and Antibodies to SARS-CoV-2 in Donated Blood in the US

Estimated SARS-CoV-2 Seroprevalence in the US as of

High COVID-19 Attack Rate Among Attendees at Events at a Church -Arkansas

The Translational Research Institute at UAMS provided support for logistics, coordination and implementation of this project, including provision of an honest broker, secure data storage and management through REDCap (NCATS/NIH 1 UL1 RR029884).